Amazon, Motorola Solutions, PTC, Liberty Global and Advantech were among the investors that supplied extra series B-1 funding for the smart contact lens provider helping to push wearable technology to the next level.

Veon and Prosus helped B2B product marketplace ShopUp push its series B funding to $109m while Sunshine Insurance backed rounds for ImmuneOnco and Xuanzhu Biopharmaceutical.

Zebra Technologies took part in a $25.8m round for the retail automation technology provider as offline retailers look to automate to compete with e-commerce.

Live Nation was among the investors that supported the Pernod Ricard-backed heavy water retailer, which is benefitting from a series of memorable marketing initiatives.

Baidu Ventures has backed the small molecule cancer therapy developer’s latest round, which came after a slew of healthtech and biotech investments made by the unit in recent months.

In the first part of our look at 2021's corporate venturing trends, we examine the growth in funding, IPOs and SPAC mergers, a big year for M&A and the emergence of CVC in new sectors.

Data storage technology producer Dera pulled in over $150m through a China Unicom-backed series C round while GlobalBees raised in excess of $110m in a round featuring SoftBank and FirstCry.

Multiple corporates have helped staffing software provider Paradox close a $200m series C round, and electronic parts maker BOE Technology is putting up about $47m in a Chinese state-backed vehicle.

Chinese drug discovery platform QureBio raised corporate funding last week while JD.com and Qi-Anxin Technology Group were among the LPs that helped set up the $470m Shoudu Pan Healthcare Industry Fund.

Drug development platform creator Xbiome has raised nearly $100m in series B funding while bioindustrial startup services provider 21st.Bio secured a similar amount from Novo.